Concepts (326)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Benzo(a)pyrene | 41 | 2022 | 128 | 9.300 |
Why?
|
| Colonic Neoplasms | 12 | 2021 | 223 | 4.220 |
Why?
|
| Fluorenes | 8 | 2013 | 26 | 2.230 |
Why?
|
| Carcinogens | 10 | 2016 | 126 | 2.000 |
Why?
|
| Environmental Pollutants | 10 | 2014 | 198 | 1.710 |
Why?
|
| Disease Models, Animal | 10 | 2025 | 1554 | 1.470 |
Why?
|
| Environmental Exposure | 5 | 2025 | 247 | 1.420 |
Why?
|
| Air Pollutants | 6 | 2025 | 127 | 1.350 |
Why?
|
| Liver | 10 | 2020 | 503 | 1.280 |
Why?
|
| Carcinogens, Environmental | 6 | 2018 | 35 | 1.240 |
Why?
|
| Endocrine Disruptors | 3 | 2023 | 43 | 1.140 |
Why?
|
| Ovary | 5 | 2022 | 112 | 1.120 |
Why?
|
| DNA Adducts | 6 | 2018 | 41 | 1.110 |
Why?
|
| Dietary Fats | 4 | 2013 | 117 | 1.030 |
Why?
|
| Particulate Matter | 2 | 2025 | 80 | 1.010 |
Why?
|
| Biotransformation | 6 | 2018 | 68 | 0.980 |
Why?
|
| Animals | 49 | 2025 | 16695 | 0.920 |
Why?
|
| Education, Medical | 2 | 2023 | 117 | 0.890 |
Why?
|
| Gastrointestinal Tract | 3 | 2014 | 67 | 0.840 |
Why?
|
| Testis | 7 | 2022 | 203 | 0.760 |
Why?
|
| Saliva | 1 | 2023 | 115 | 0.740 |
Why?
|
| Chromatography, High Pressure Liquid | 9 | 2022 | 458 | 0.730 |
Why?
|
| Atmospheric Pressure | 1 | 2020 | 11 | 0.660 |
Why?
|
| Rats, Inbred F344 | 16 | 2012 | 256 | 0.660 |
Why?
|
| Vascular Diseases | 1 | 2020 | 33 | 0.650 |
Why?
|
| Pressure | 1 | 2020 | 49 | 0.650 |
Why?
|
| Genes, APC | 3 | 2015 | 15 | 0.640 |
Why?
|
| Rats | 26 | 2016 | 3701 | 0.640 |
Why?
|
| Aorta | 4 | 2016 | 197 | 0.630 |
Why?
|
| Microsomes, Liver | 3 | 2016 | 71 | 0.610 |
Why?
|
| Subcellular Fractions | 3 | 2016 | 79 | 0.610 |
Why?
|
| Chromatography, Liquid | 1 | 2020 | 173 | 0.600 |
Why?
|
| Mass Spectrometry | 1 | 2020 | 279 | 0.590 |
Why?
|
| Male | 36 | 2023 | 22779 | 0.580 |
Why?
|
| Aortic Aneurysm, Abdominal | 2 | 2015 | 19 | 0.570 |
Why?
|
| Mice | 16 | 2022 | 6490 | 0.530 |
Why?
|
| Humans | 33 | 2025 | 42163 | 0.520 |
Why?
|
| Microsomes | 4 | 2010 | 55 | 0.480 |
Why?
|
| Body Burden | 1 | 2014 | 7 | 0.460 |
Why?
|
| Colonic Polyps | 2 | 2012 | 70 | 0.430 |
Why?
|
| Female | 29 | 2023 | 24018 | 0.430 |
Why?
|
| Adenocarcinoma | 2 | 2013 | 287 | 0.420 |
Why?
|
| Administration, Oral | 8 | 2015 | 256 | 0.410 |
Why?
|
| Schools, Medical | 3 | 2025 | 208 | 0.400 |
Why?
|
| Colon | 2 | 2013 | 118 | 0.390 |
Why?
|
| Risk Assessment | 4 | 2013 | 845 | 0.380 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2018 | 933 | 0.380 |
Why?
|
| Stilbenes | 1 | 2012 | 44 | 0.370 |
Why?
|
| Soil Pollutants | 1 | 2013 | 104 | 0.370 |
Why?
|
| Gastrointestinal Neoplasms | 1 | 2011 | 23 | 0.360 |
Why?
|
| Cytological Techniques | 1 | 2011 | 14 | 0.360 |
Why?
|
| Tissue Distribution | 7 | 2018 | 230 | 0.350 |
Why?
|
| Biological Availability | 7 | 2015 | 115 | 0.350 |
Why?
|
| Oxidative Stress | 2 | 2015 | 990 | 0.350 |
Why?
|
| Cytochrome P-450 CYP1A1 | 5 | 2018 | 52 | 0.350 |
Why?
|
| Opioid-Related Disorders | 2 | 2023 | 188 | 0.320 |
Why?
|
| Fertility | 2 | 2012 | 63 | 0.310 |
Why?
|
| Prenatal Exposure Delayed Effects | 5 | 2015 | 188 | 0.300 |
Why?
|
| Lung | 5 | 2012 | 484 | 0.300 |
Why?
|
| Aryl Hydrocarbon Hydroxylases | 4 | 2013 | 51 | 0.300 |
Why?
|
| Adipose Tissue | 1 | 2010 | 180 | 0.290 |
Why?
|
| Dose-Response Relationship, Drug | 10 | 2015 | 1112 | 0.290 |
Why?
|
| Students, Medical | 2 | 2021 | 153 | 0.280 |
Why?
|
| Cell Proliferation | 3 | 2021 | 1420 | 0.270 |
Why?
|
| Behavior, Animal | 6 | 2015 | 369 | 0.270 |
Why?
|
| Fetus | 3 | 2015 | 101 | 0.260 |
Why?
|
| Spermatozoa | 1 | 2008 | 208 | 0.250 |
Why?
|
| Anti-HIV Agents | 2 | 2021 | 475 | 0.250 |
Why?
|
| Cardiovascular Diseases | 2 | 2025 | 729 | 0.240 |
Why?
|
| Intestine, Small | 1 | 2005 | 25 | 0.240 |
Why?
|
| Diethylstilbestrol | 1 | 2004 | 7 | 0.230 |
Why?
|
| Estrogens, Non-Steroidal | 1 | 2004 | 21 | 0.230 |
Why?
|
| Research Support as Topic | 1 | 2025 | 89 | 0.220 |
Why?
|
| Prevalence | 2 | 2023 | 1597 | 0.220 |
Why?
|
| Fluorescence | 2 | 2020 | 113 | 0.220 |
Why?
|
| Catalase | 3 | 2016 | 111 | 0.210 |
Why?
|
| Enzyme Inhibitors | 2 | 2005 | 457 | 0.210 |
Why?
|
| Neurosecretory Systems | 1 | 2023 | 17 | 0.210 |
Why?
|
| RNA, Small Interfering | 2 | 2025 | 436 | 0.210 |
Why?
|
| Sheep | 3 | 2009 | 77 | 0.200 |
Why?
|
| Buprenorphine | 1 | 2023 | 51 | 0.200 |
Why?
|
| Reproduction | 1 | 2023 | 92 | 0.200 |
Why?
|
| Estrogens | 2 | 2023 | 202 | 0.200 |
Why?
|
| Apolipoproteins E | 2 | 2015 | 137 | 0.200 |
Why?
|
| Apoptosis | 3 | 2018 | 1541 | 0.200 |
Why?
|
| Swine | 3 | 2009 | 205 | 0.190 |
Why?
|
| Diet | 2 | 2005 | 810 | 0.190 |
Why?
|
| Microcephaly | 1 | 2022 | 21 | 0.190 |
Why?
|
| Gonads | 1 | 2022 | 21 | 0.190 |
Why?
|
| Pregnancy, Animal | 1 | 2022 | 15 | 0.180 |
Why?
|
| Mentors | 1 | 2023 | 143 | 0.180 |
Why?
|
| Melanoma | 1 | 2023 | 109 | 0.180 |
Why?
|
| Cattle | 3 | 2009 | 505 | 0.180 |
Why?
|
| Pregnancy | 11 | 2022 | 1737 | 0.180 |
Why?
|
| Inhalation Exposure | 3 | 2011 | 44 | 0.180 |
Why?
|
| Skin Neoplasms | 1 | 2023 | 175 | 0.180 |
Why?
|
| Community Health Services | 1 | 2023 | 207 | 0.170 |
Why?
|
| Cell Cycle | 2 | 2013 | 348 | 0.170 |
Why?
|
| Mice, Mutant Strains | 2 | 2012 | 85 | 0.170 |
Why?
|
| Placenta | 1 | 2022 | 113 | 0.170 |
Why?
|
| Porosity | 1 | 2020 | 42 | 0.160 |
Why?
|
| Antidepressive Agents, Tricyclic | 1 | 2000 | 15 | 0.160 |
Why?
|
| Bisexuality | 1 | 2023 | 210 | 0.160 |
Why?
|
| Biomedical Research | 1 | 2025 | 467 | 0.160 |
Why?
|
| Glutathione Transferase | 2 | 2018 | 90 | 0.160 |
Why?
|
| Stereoisomerism | 1 | 2020 | 166 | 0.160 |
Why?
|
| Students, Dental | 1 | 2019 | 6 | 0.160 |
Why?
|
| Solvents | 1 | 2020 | 109 | 0.160 |
Why?
|
| Air Pollution | 1 | 2020 | 87 | 0.150 |
Why?
|
| Drug Interactions | 2 | 2013 | 151 | 0.150 |
Why?
|
| Time Factors | 4 | 2022 | 1848 | 0.150 |
Why?
|
| Students, Nursing | 1 | 2019 | 37 | 0.150 |
Why?
|
| Organ Size | 3 | 2009 | 167 | 0.150 |
Why?
|
| Social Environment | 1 | 2020 | 218 | 0.150 |
Why?
|
| Prejudice | 1 | 2019 | 116 | 0.150 |
Why?
|
| Physicians | 1 | 2021 | 180 | 0.150 |
Why?
|
| Gene Expression Regulation, Developmental | 2 | 2015 | 303 | 0.150 |
Why?
|
| Sexual Behavior | 1 | 2023 | 634 | 0.140 |
Why?
|
| DNA Damage | 1 | 2021 | 358 | 0.140 |
Why?
|
| Brain | 5 | 2011 | 1452 | 0.140 |
Why?
|
| Physician-Patient Relations | 1 | 2019 | 146 | 0.140 |
Why?
|
| Macrophages | 3 | 2022 | 515 | 0.140 |
Why?
|
| Water | 1 | 2020 | 314 | 0.140 |
Why?
|
| United States | 6 | 2025 | 5072 | 0.140 |
Why?
|
| Cross-Sectional Studies | 2 | 2023 | 3077 | 0.130 |
Why?
|
| Attitude of Health Personnel | 1 | 2019 | 222 | 0.130 |
Why?
|
| Body Weight | 3 | 2009 | 428 | 0.130 |
Why?
|
| Cells, Cultured | 5 | 2016 | 1617 | 0.130 |
Why?
|
| Tumor Cells, Cultured | 1 | 2018 | 506 | 0.130 |
Why?
|
| Risk Factors | 2 | 2023 | 3942 | 0.130 |
Why?
|
| Mice, Knockout | 3 | 2015 | 1010 | 0.130 |
Why?
|
| Mice, Inbred C57BL | 5 | 2022 | 1804 | 0.130 |
Why?
|
| Cerebral Cortex | 3 | 2010 | 303 | 0.130 |
Why?
|
| Luteinizing Hormone | 4 | 2012 | 62 | 0.130 |
Why?
|
| Rats, Mutant Strains | 1 | 2016 | 7 | 0.130 |
Why?
|
| HIV Infections | 2 | 2021 | 2535 | 0.130 |
Why?
|
| Receptors, Aryl Hydrocarbon | 2 | 2009 | 49 | 0.130 |
Why?
|
| Nystatin | 1 | 2016 | 6 | 0.120 |
Why?
|
| Eating | 2 | 2009 | 164 | 0.120 |
Why?
|
| beta-Cyclodextrins | 1 | 2016 | 35 | 0.120 |
Why?
|
| Cricetinae | 2 | 2007 | 241 | 0.120 |
Why?
|
| Membrane Microdomains | 1 | 2016 | 53 | 0.120 |
Why?
|
| Myometrium | 1 | 2015 | 15 | 0.120 |
Why?
|
| Species Specificity | 2 | 2007 | 279 | 0.120 |
Why?
|
| Transcription Factor RelA | 1 | 2015 | 41 | 0.120 |
Why?
|
| Random Allocation | 3 | 2015 | 145 | 0.110 |
Why?
|
| Histone Deacetylases | 1 | 2015 | 61 | 0.110 |
Why?
|
| Tennessee | 1 | 2014 | 88 | 0.110 |
Why?
|
| Discrimination Learning | 2 | 2011 | 35 | 0.110 |
Why?
|
| Antioxidants | 1 | 2018 | 439 | 0.110 |
Why?
|
| Neuronal Plasticity | 2 | 2007 | 126 | 0.110 |
Why?
|
| Animals, Newborn | 4 | 2004 | 350 | 0.110 |
Why?
|
| Chromatography, Thin Layer | 1 | 2013 | 39 | 0.110 |
Why?
|
| Administration, Inhalation | 5 | 2012 | 92 | 0.110 |
Why?
|
| Estrous Cycle | 2 | 2012 | 37 | 0.100 |
Why?
|
| Age Factors | 2 | 2014 | 1139 | 0.100 |
Why?
|
| Endothelial Cells | 1 | 2016 | 324 | 0.100 |
Why?
|
| HT29 Cells | 1 | 2013 | 60 | 0.100 |
Why?
|
| Meat | 1 | 2013 | 46 | 0.100 |
Why?
|
| Rats, Long-Evans | 5 | 2015 | 108 | 0.100 |
Why?
|
| Caspase 3 | 1 | 2013 | 226 | 0.090 |
Why?
|
| Adenomatous Polyposis Coli Protein | 1 | 2012 | 9 | 0.090 |
Why?
|
| Testosterone | 3 | 2008 | 211 | 0.090 |
Why?
|
| Cell Transformation, Neoplastic | 1 | 2013 | 165 | 0.090 |
Why?
|
| Maternal Exposure | 2 | 2010 | 56 | 0.090 |
Why?
|
| NADPH-Ferrihemoprotein Reductase | 1 | 2011 | 10 | 0.090 |
Why?
|
| Chemical Fractionation | 1 | 2011 | 14 | 0.090 |
Why?
|
| Sonication | 1 | 2011 | 14 | 0.090 |
Why?
|
| Detergents | 1 | 2011 | 25 | 0.090 |
Why?
|
| Freeze Drying | 1 | 2011 | 29 | 0.090 |
Why?
|
| Solid Phase Extraction | 1 | 2011 | 13 | 0.090 |
Why?
|
| Superoxide Dismutase | 2 | 2009 | 158 | 0.090 |
Why?
|
| Infant | 1 | 2014 | 1143 | 0.090 |
Why?
|
| Anticarcinogenic Agents | 1 | 2011 | 74 | 0.090 |
Why?
|
| Analgesics, Opioid | 2 | 2023 | 245 | 0.080 |
Why?
|
| Sperm Motility | 2 | 2008 | 45 | 0.080 |
Why?
|
| Analysis of Variance | 1 | 2012 | 574 | 0.080 |
Why?
|
| Chromatography, Reverse-Phase | 1 | 2010 | 9 | 0.080 |
Why?
|
| Embryo, Mammalian | 1 | 2010 | 158 | 0.080 |
Why?
|
| Models, Biological | 1 | 2013 | 711 | 0.080 |
Why?
|
| Environmental Monitoring | 1 | 2011 | 226 | 0.080 |
Why?
|
| Plasma | 1 | 2010 | 38 | 0.080 |
Why?
|
| Aerosols | 3 | 2011 | 53 | 0.080 |
Why?
|
| Sex Factors | 2 | 2022 | 1008 | 0.080 |
Why?
|
| Disease Susceptibility | 1 | 2010 | 101 | 0.080 |
Why?
|
| Models, Animal | 1 | 2009 | 149 | 0.080 |
Why?
|
| Spectrometry, Fluorescence | 1 | 2010 | 184 | 0.080 |
Why?
|
| Neurotoxicity Syndromes | 2 | 2006 | 37 | 0.070 |
Why?
|
| Middle Aged | 3 | 2020 | 11819 | 0.070 |
Why?
|
| Somatosensory Cortex | 1 | 2008 | 24 | 0.070 |
Why?
|
| Neurons | 4 | 2011 | 1246 | 0.070 |
Why?
|
| Cod Liver Oil | 1 | 2008 | 1 | 0.070 |
Why?
|
| Absorption | 1 | 2008 | 22 | 0.070 |
Why?
|
| Half-Life | 1 | 2008 | 63 | 0.070 |
Why?
|
| Plant Oils | 1 | 2008 | 20 | 0.070 |
Why?
|
| Caprylates | 1 | 2008 | 10 | 0.070 |
Why?
|
| Area Under Curve | 1 | 2008 | 95 | 0.070 |
Why?
|
| Aged, 80 and over | 1 | 2014 | 2803 | 0.070 |
Why?
|
| Solubility | 1 | 2008 | 134 | 0.070 |
Why?
|
| Triglycerides | 1 | 2008 | 146 | 0.070 |
Why?
|
| Endothelium, Vascular | 1 | 2009 | 261 | 0.070 |
Why?
|
| Receptors, Glutamate | 1 | 2007 | 27 | 0.070 |
Why?
|
| Mesocricetus | 1 | 2007 | 56 | 0.070 |
Why?
|
| Environment | 1 | 2008 | 148 | 0.060 |
Why?
|
| Organ Specificity | 1 | 2007 | 141 | 0.060 |
Why?
|
| Jejunum | 1 | 2006 | 7 | 0.060 |
Why?
|
| Child | 1 | 2014 | 3381 | 0.060 |
Why?
|
| Dietary Fats, Unsaturated | 1 | 2006 | 9 | 0.060 |
Why?
|
| Particle Size | 2 | 2011 | 267 | 0.060 |
Why?
|
| Phosphorus Radioisotopes | 1 | 2005 | 9 | 0.060 |
Why?
|
| Haplorhini | 1 | 2005 | 23 | 0.060 |
Why?
|
| Goats | 1 | 2005 | 22 | 0.060 |
Why?
|
| RNA, Messenger | 5 | 2010 | 1265 | 0.060 |
Why?
|
| Dogs | 1 | 2005 | 201 | 0.060 |
Why?
|
| Toxicity Tests, Chronic | 1 | 2004 | 1 | 0.060 |
Why?
|
| No-Observed-Adverse-Effect Level | 1 | 2004 | 4 | 0.060 |
Why?
|
| Hematologic Tests | 1 | 2004 | 7 | 0.060 |
Why?
|
| Adult | 2 | 2014 | 13458 | 0.050 |
Why?
|
| Complex Mixtures | 1 | 2004 | 9 | 0.050 |
Why?
|
| Behavior | 1 | 2004 | 34 | 0.050 |
Why?
|
| Cell Line, Tumor | 1 | 2011 | 2598 | 0.050 |
Why?
|
| Feces | 1 | 2004 | 126 | 0.050 |
Why?
|
| Food Contamination | 1 | 2004 | 55 | 0.050 |
Why?
|
| Epididymis | 1 | 2003 | 27 | 0.050 |
Why?
|
| Prostate | 1 | 2004 | 152 | 0.050 |
Why?
|
| Adolescent | 1 | 2014 | 5950 | 0.050 |
Why?
|
| Cerebellum | 2 | 2002 | 78 | 0.050 |
Why?
|
| Central Nervous System | 1 | 2004 | 150 | 0.050 |
Why?
|
| Receptors, N-Methyl-D-Aspartate | 3 | 2011 | 133 | 0.050 |
Why?
|
| Fetal Death | 1 | 2002 | 18 | 0.050 |
Why?
|
| Naloxone | 1 | 2023 | 56 | 0.050 |
Why?
|
| SEER Program | 1 | 2023 | 157 | 0.050 |
Why?
|
| Education, Medical, Graduate | 1 | 2023 | 61 | 0.050 |
Why?
|
| Rats, Sprague-Dawley | 2 | 2004 | 1737 | 0.050 |
Why?
|
| Faculty | 1 | 2023 | 105 | 0.050 |
Why?
|
| Food Supply | 1 | 2004 | 120 | 0.050 |
Why?
|
| Brazil | 1 | 2022 | 83 | 0.050 |
Why?
|
| Inflammation | 2 | 2022 | 729 | 0.050 |
Why?
|
| Aged | 1 | 2014 | 7982 | 0.050 |
Why?
|
| Keratins | 1 | 2022 | 25 | 0.050 |
Why?
|
| Skin | 1 | 2023 | 185 | 0.050 |
Why?
|
| Enzyme Activation | 2 | 2000 | 462 | 0.050 |
Why?
|
| Kidney | 1 | 2004 | 363 | 0.050 |
Why?
|
| Signal Transduction | 2 | 2025 | 2111 | 0.050 |
Why?
|
| Genitalia, Male | 1 | 2001 | 14 | 0.050 |
Why?
|
| Proportional Hazards Models | 1 | 2023 | 512 | 0.050 |
Why?
|
| Mice, Transgenic | 2 | 2016 | 658 | 0.040 |
Why?
|
| Lead | 2 | 1999 | 101 | 0.040 |
Why?
|
| Universities | 1 | 2025 | 539 | 0.040 |
Why?
|
| Educational Status | 1 | 2023 | 335 | 0.040 |
Why?
|
| Cohort Studies | 2 | 2020 | 1729 | 0.040 |
Why?
|
| Phenotype | 2 | 2015 | 774 | 0.040 |
Why?
|
| Health Personnel | 1 | 2023 | 262 | 0.040 |
Why?
|
| Primary Health Care | 1 | 2023 | 362 | 0.040 |
Why?
|
| Ornithine Decarboxylase | 1 | 1999 | 10 | 0.040 |
Why?
|
| Neocortex | 1 | 1999 | 27 | 0.040 |
Why?
|
| Community Health Centers | 1 | 2020 | 56 | 0.040 |
Why?
|
| Gene Expression Regulation | 1 | 2025 | 1066 | 0.040 |
Why?
|
| Lead Poisoning | 1 | 1999 | 25 | 0.040 |
Why?
|
| Reference Values | 1 | 2000 | 207 | 0.040 |
Why?
|
| Monocytes | 1 | 2022 | 275 | 0.040 |
Why?
|
| Computational Biology | 1 | 2022 | 324 | 0.040 |
Why?
|
| Incidence | 1 | 2022 | 1054 | 0.040 |
Why?
|
| Treatment Outcome | 1 | 2023 | 1586 | 0.040 |
Why?
|
| Spermine | 1 | 1999 | 65 | 0.040 |
Why?
|
| Protein Kinase C | 1 | 1999 | 124 | 0.040 |
Why?
|
| Litter Size | 2 | 2012 | 14 | 0.040 |
Why?
|
| Sensitivity and Specificity | 1 | 2000 | 602 | 0.040 |
Why?
|
| Progesterone | 2 | 2012 | 120 | 0.040 |
Why?
|
| Students | 1 | 2023 | 617 | 0.030 |
Why?
|
| Down-Regulation | 2 | 2010 | 452 | 0.030 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 2 | 2009 | 649 | 0.030 |
Why?
|
| Xenobiotics | 1 | 2016 | 14 | 0.030 |
Why?
|
| Peroxides | 1 | 2016 | 21 | 0.030 |
Why?
|
| Retrospective Studies | 1 | 2023 | 2485 | 0.030 |
Why?
|
| Reproducibility of Results | 1 | 2000 | 1058 | 0.030 |
Why?
|
| Receptors, IgG | 1 | 2016 | 53 | 0.030 |
Why?
|
| Endoplasmic Reticulum | 1 | 2016 | 108 | 0.030 |
Why?
|
| Microscopy, Fluorescence | 1 | 2016 | 254 | 0.030 |
Why?
|
| Muscle Proteins | 1 | 2015 | 52 | 0.030 |
Why?
|
| Homosexuality, Male | 1 | 2021 | 483 | 0.030 |
Why?
|
| Isoenzymes | 1 | 2015 | 169 | 0.030 |
Why?
|
| Immunoglobulin G | 1 | 2016 | 253 | 0.030 |
Why?
|
| Apoptosis Regulatory Proteins | 1 | 2015 | 160 | 0.030 |
Why?
|
| Premature Birth | 1 | 2015 | 94 | 0.030 |
Why?
|
| Aging | 1 | 1999 | 764 | 0.030 |
Why?
|
| Health Status Disparities | 1 | 2020 | 705 | 0.030 |
Why?
|
| Ovulation | 1 | 2012 | 21 | 0.020 |
Why?
|
| Follicle Stimulating Hormone | 1 | 2012 | 44 | 0.020 |
Why?
|
| Cyclophilin A | 1 | 2012 | 19 | 0.020 |
Why?
|
| Soot | 1 | 2011 | 9 | 0.020 |
Why?
|
| Motor Activity | 2 | 2006 | 438 | 0.020 |
Why?
|
| Cytokines | 1 | 2015 | 661 | 0.020 |
Why?
|
| Matrix Metalloproteinase 9 | 1 | 2012 | 95 | 0.020 |
Why?
|
| Angiotensin II | 1 | 2012 | 103 | 0.020 |
Why?
|
| Proto-Oncogene Proteins c-met | 1 | 2010 | 9 | 0.020 |
Why?
|
| Glutamic Acid | 1 | 2011 | 131 | 0.020 |
Why?
|
| Estradiol | 1 | 2012 | 269 | 0.020 |
Why?
|
| Exploratory Behavior | 1 | 2010 | 78 | 0.020 |
Why?
|
| Autistic Disorder | 1 | 2010 | 38 | 0.020 |
Why?
|
| Oxidation-Reduction | 1 | 2011 | 448 | 0.020 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2012 | 379 | 0.020 |
Why?
|
| F2-Isoprostanes | 1 | 2009 | 20 | 0.020 |
Why?
|
| Furans | 1 | 2009 | 39 | 0.020 |
Why?
|
| Reaction Time | 1 | 2008 | 151 | 0.020 |
Why?
|
| Gene Expression | 1 | 2010 | 692 | 0.020 |
Why?
|
| Blotting, Western | 1 | 2009 | 884 | 0.020 |
Why?
|
| Receptors, AMPA | 1 | 2007 | 57 | 0.020 |
Why?
|
| Electrophysiology | 1 | 2007 | 138 | 0.020 |
Why?
|
| Up-Regulation | 1 | 2009 | 534 | 0.020 |
Why?
|
| Cognition | 1 | 2010 | 458 | 0.020 |
Why?
|
| Glutathione Peroxidase | 1 | 2006 | 100 | 0.020 |
Why?
|
| Lipid Peroxidation | 1 | 2006 | 141 | 0.020 |
Why?
|
| Immunohistochemistry | 1 | 2007 | 928 | 0.010 |
Why?
|
| Culture Techniques | 1 | 2003 | 26 | 0.010 |
Why?
|
| Maternal-Fetal Exchange | 1 | 2003 | 22 | 0.010 |
Why?
|
| Radioimmunoassay | 1 | 2003 | 70 | 0.010 |
Why?
|
| Long-Term Potentiation | 1 | 2004 | 109 | 0.010 |
Why?
|
| Psychomotor Performance | 1 | 2004 | 156 | 0.010 |
Why?
|
| Pregnancy Outcome | 1 | 2003 | 92 | 0.010 |
Why?
|
| Prolactin | 1 | 2002 | 64 | 0.010 |
Why?
|
| Embryo Implantation | 1 | 2002 | 32 | 0.010 |
Why?
|
| Embryonic Development | 1 | 2002 | 83 | 0.010 |
Why?
|
| Staurosporine | 1 | 1999 | 38 | 0.010 |
Why?
|
| PC12 Cells | 1 | 1999 | 93 | 0.010 |
Why?
|
| Neurotoxins | 1 | 1999 | 55 | 0.010 |
Why?
|